Calixarene: A Versatile Material for Drug Design and Applications
Muhammad A Hussain1, Muhammad U Ashraf2, Gulzar Muhammad3
1Department of Chemistry, University of Sargodha, Sargodha 40100. Pakistan.
Current Pharmaceutical Design
|October 26, 2016
Summary
Calixarene derivatives are versatile drug carriers, enhancing solubility and enabling targeted delivery for various diseases. These macrocyclic compounds show promise in supramolecular chemistry for improved drug efficacy and reduced side effects.
Area of Science:
- Supramolecular Chemistry
- Materials Science
- Medicinal Chemistry
Background:
- Calixarenes are macrocyclic compounds with unique host-guest properties.
- They function as nano-baskets capable of encapsulating guest molecules, including drugs.
- Their biocompatibility and ability to form inclusion complexes are key features.
Purpose of the Study:
- To review the application of calixarene derivatives in drug therapy.
- To highlight their role in host-guest chemistry for drug encapsulation and delivery.
- To evaluate their potential in developing prodrugs and improving drug properties.
Main Methods:
- Literature review of studies on calixarene-drug inclusion complexes.
- Analysis of calixarene derivatives as drug carriers for various therapeutic agents.
- Evaluation of supramolecular interactions for enhanced drug solubility and targeted release.
Main Results:
- Calixarene derivatives effectively form inclusion complexes with diverse drugs and vitamins.
- These complexes facilitate sustained and targeted drug release.
- Calixarenes improve solubility, reactivity, and reduce cytotoxicity of poorly soluble drugs.
Conclusions:
- Calixarene derivatives are advanced materials for drug delivery systems.
- They offer significant advantages in improving the therapeutic profile of various drugs.
- Further research into calixarene-based prodrugs holds substantial promise.
More Related Videos
Related Concept Videos
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Targets for Drug Action: Overview
10.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.9K


